Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function

Although pancreatic neuroendocrine neoplasms (panNENs) are much less common and have a better prognosis than exocrine pancreatic cancers, their recurrence rate is not low, even in Grade 1 (World Health Organization classification) panNEN. Recently, there have been several reports that the progressio...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Shogo Maruzen, Seiichi Munesue, Mitsuyoshi Okazaki, Satoshi Takada, Shinichi Nakanuma, Isamu Makino, Linxiang Gong, Susumu Kohno, Chiaki Takahashi, Hidehiro Tajima, Yasuhiko Yamamoto, Shintaro Yagi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2024-04-01
Serie:	Onco
Soggetti:	panNEN progression-free survival metformin AMPK activation suppressed mitochondrial respiration
Accesso online:	https://www.mdpi.com/2673-7523/4/2/7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!